DPIIT recognised startup Government of India
Startup India
Meditimes Pharma Private Limited
Meditimes Pharma Private Limited - trading in Surat, Gujarat, India. Directors, charges & compliance details.
Revenue · FY 2025
₹76.93 Lakh
▲ 75% YoY
Net profit · FY 2025
₹65,052
Net margin 0.8%
EBITDA · FY 2025
₹1.55 Lakh
EBITDA margin 2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Meditimes Pharma Private Limited
Data last updated:
Meditimes Pharma Private Limited is a private limited company based in Surat, Gujarat, India, recognised as a startup by DPIIT. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 15 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2021PTC124144.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhaveshbhai Amipara and Bhavinbhai Vrajlal Raja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hno.7 Gokul Park V – 3 Opp.Utran Railway Station Utran, Surat, Gujarat, India – 394105.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.93 Lakh, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹65,052 (net margin 0.8%) and EBITDA of ₹1.55 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 75% over three years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Company details
CIN U51909GJ2021PTC124144
Registration Number 124144
Incorporation Date 15 July 2021
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
Key People
Bhaveshbhai Amipara Director Bhavinbhai Vrajlal Raja Director Niraj Piyushbhai Bhatt Director Recognitions & Rankings of Meditimes Pharma
Contact details
Meditimes Pharma Private Limited's registered office is in Surat, Gujarat.
- Registered AddressHno.7 Gokul Park V – 3 Opp.Utran Railway Station Utran, Surat, Gujarat, India – 394105
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Meditimes Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Meditimes Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Meditimes Pharma Private Limited, buy the company report.
Financials of Meditimes Pharma Private Limited
FY 2025 filings availableMeditimes Pharma Private Limited reported revenue of ₹76.93 Lakh (up 75% YoY) for FY 2025.
Revenue · FY 2025
₹76.93 Lakh ▲ 75%
Net profit · FY 2025
₹65,052 margin 0.8%
EBITDA · FY 2025
₹1.55 Lakh margin 2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 75%
3 years · compounded
▲ 75%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 75%
Revenue has grown at a compounded annual rate (CAGR) of 75% over three years, including 75% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.55 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹65,052 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2% | |||
| Net Profit Margin | 0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Meditimes Pharma Private Limited, buy the company report.
Board of directors of Meditimes Pharma Private Limited
Meditimes Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaveshbhai Amipara | Director | 15 Jul 2021 | 5 Years 4 Months | Current |
| Bhavinbhai Vrajlal Raja | Director | 15 Jul 2021 | 5 Years 4 Months | Current |
| Niraj Piyushbhai Bhatt | Director | 16 Dec 2023 | 2 Years 10 Months | Current |
| Dharmendrakumar Bholabhai Ramani | Director | 05 Aug 2025 | 1 Years 3 Months | Current |
Peer comparison
Meditimes Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hiral Remedies Private Limited | ₹76.97 Lakh (FY 2024) | -6.0% | Kasipur, Uttarakhand, India | |||
| Harshvardhan Agri Products Trading Private Limited | ₹76.97 Lakh (FY 2025) | 124.0% | Tasgaon, Maharashtra, India | |||
| Esskot Lifesciences Private Limited | ₹76.97 Lakh (FY 2024) | 14.0% | Ahmedabad, Gujarat, India | |||
| Suraj Plastics Private Limited | ₹76.96 Lakh (FY 2025) | -14.0% | Kolkata, West Bengal, India | |||
| Link Consultants Pvt Ltd | ₹76.95 Lakh (FY 2020) | 15.0% | Kolkata, West Bengal, India | |||
| Meditimes Pharma Private Limitedthis company | ₹76.93 Lakh (FY 2025) | ₹65,052 | 0.8% | 75.0% | Surat, Gujarat, India | |
| Gandharwa Properties Pvt Ltd | ₹76.93 Lakh (FY 2025) | 1.0% | Kolkata, West Bengal, India | |||
| Zeromed Integrated Printing Solutions Private Limited | ₹76.9 Lakh (FY 2025) | 24.0% | Jalandhar, Punjab, India | |||
| Glaube International Private Limited | ₹76.9 Lakh (FY 2023) | 98.0% | Kozhikode, Kerala, India | |||
| Maxpro Amazing Equipments Private Limited | ₹76.89 Lakh (FY 2025) | 25.0% | Coimbatore, Tamil Nadu, India | |||
| GDCD International Private Limited | ₹76.89 Lakh (FY 2024) | -36.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Meditimes Pharma Private Limited, buy the company report.
Legal cases
Meditimes Pharma Private Limited has 1 court case on record: 1 filed by Meditimes Pharma. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, SURAT, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
To see the full case history of Meditimes Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meditimes Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Meditimes Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Meditimes Pharma Private Limited has 8 board changes on record since 2021: 5 appointments and 3 cessations. The latest: Dharmendrakumar Bholabhai Ramani was appointed as Director on 05 Aug 2025.
AGM
Meditimes Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Dharmendrakumar Bholabhai Ramani was appointed as Director.
Filing
Meditimes Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Niraj Piyushbhai Bhatt was appointed as Director.
Ceased
Chandresh Dhirubhai Bhanderi ceased to be Director.
Appointed
Amit Hemarajbhai Tala was appointed as Director.
Ceased
Amit Hemarajbhai Tala ceased to be Director.
Ceased
Kishankumar Bhanderi ceased to be Director.
Appointed
Bhaveshbhai Amipara was appointed as Director.
Appointed
Bhavinbhai Vrajlal Raja was appointed as Director.
Incorporation
15 Jul 2021
Meditimes Pharma Private Limited was registered on 15 Jul 2021 with Roc Ahmedabad & aged 5 years 4 months as per MCA records.
Frequently asked questions
Meditimes Pharma is an active private limited company based in Surat, Gujarat, India. The company works in specialty, within the trading industry. It was incorporated on 15 July 2021 (5+ years old) and is registered under CIN U51909GJ2021PTC124144.
Meditimes Pharma has 4 current directors:
- Bhaveshbhai Amipara - Director
- Bhavinbhai Vrajlal Raja - Director
- Niraj Piyushbhai Bhatt - Director
- Dharmendrakumar Bholabhai Ramani - Director
The latest financial statements of Meditimes Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Meditimes Pharma is U51909GJ2021PTC124144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meditimes Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Meditimes Pharma was incorporated on 15 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Meditimes Pharma by revenue are Hiral Remedies Private Limited, Harshvardhan Agri Products Trading Private Limited, Esskot Lifesciences Private Limited, Suraj Plastics Private Limited, Link Consultants Pvt Ltd and 5 more, all in the same principal business activity (wholesale trading).
Dharmendrakumar Bholabhai Ramani was appointed as Director on 05 Aug 2025. Niraj Piyushbhai Bhatt was appointed as Director on 16 Dec 2023. Chandresh Dhirubhai Bhanderi ceased to be Director on 09 Nov 2023. Meditimes Pharma has 8 board changes on record in total.
Yes, Meditimes Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Meditimes Pharma is at Hno.7 Gokul Park V – 3 Opp.Utran Railway Station Utran, Surat, Gujarat, India – 394105.
Meditimes Pharma operates in the trading industry, in the specialty segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages